Abstract：Objective To analyze the effect of peripheral blood CD4+ T cell count on the evaluation of drug treatment effect in patients with immune thrombocytopenia (ITP). Methods A total of 80 ITP patients admitted to Huangshan People’s Hospital, Anhui Province (hereinafter referred to as “our hospital”) from January 2018 to December 2020 who received glucocorticoid treatment after admission were selected as the study group, and 30 healthy volunteers who underwent physical examination in our hospital during the same period were selected as the control group. Difference in peripheral blood CD4+T cell count before the treatment of stndy group were compared between the two groups. The changes of peripheral blood CD4+T cell count before and after treatment were compared in the study group. The study group was divided into the effective group (62 cases) and the ineffective group (18 cases) according to the treatment effect. The disease-related indicators of the effective group and the ineffective group were compared, and the factors influencing the treatment effect were analyzed, as well as the predictive value of peripheral blood CD4+T cell count on the treatment effect. Results Before the treatment of study group, the peripheral blood CD4+T cell count of the study group was lower than that of the control group, the difference was statistically significant (P ＜ 0.05). After treatment, the peripheral blood CD4+T cell count of the study group was higher than that before treatment, the difference was statistically significant (P ＜ 0.05). The megakaryocytes count and peripheral blood CD4+T cell count of effective group were higher than those of ineffective group, and the differences were statistically significant (P ＜ 0.05). Multivariate analysis showed that megakaryocyte count and peripheral blood CD4+T cell count were the influencing factors of drug treatment effect in ITP patients (P ＜ 0.05). The area under the receiver operating characteristic curve of peripheral blood CD4+T cell count on drug treatment effect of ITP patients was 0.765 (P ＜ 0.05). Conclusion Abnormal expression of peripheral blood CD4+T cell count in ITP patients is a factor affecting the efficacy of drug treatment in ITP patients, and has certain predictive value for the efficacy of drug trextment in ITP patients.
汪琼 汪勇 吴玉玲▲. 外周血CD4+T细胞计数对免疫性血小板减少症患者药物治疗效果评估作用分析[J]. 中国医药导报, 2022, 19(23): 121-124.
WANG Qiong WANG Yong WU Yuling▲. Analysis of the effect of peripheral blood CD4+ T cell count on the evaluation of drug treatment effect in patients with immune thrombocytopenia. 中国医药导报, 2022, 19(23): 121-124.
京公网安备 11010502046598号